There’s also execution risk in Daybue - uptake trajectory, insurance coverage leading ultimately to sales - first sales numbers will tell a story
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-4551
-
- There are more pages in this discussion • 6,317 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$21.29 |
Change
0.840(4.11%) |
Mkt cap ! $2.716B |
Open | High | Low | Value | Volume |
$20.56 | $21.29 | $20.54 | $2.184M | 104.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 384 | $21.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.29 | 1310 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 308 | 21.230 |
7 | 339 | 21.220 |
6 | 373 | 21.210 |
4 | 329 | 21.200 |
5 | 1075 | 21.190 |
Price($) | Vol. | No. |
---|---|---|
21.250 | 455 | 2 |
21.260 | 205 | 3 |
21.270 | 397 | 6 |
21.280 | 274 | 5 |
21.290 | 779 | 4 |
Last trade - 10.52am 16/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online